Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Kenneth A. Follett; Richard L. Boortz-Marx; James M. Drake; Stuart DuPen; Steven J. Schneider; Michael S. Turner; Robert J. Coffey

doi:10.1097/00000542-200406000-00034

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Kenneth A. Follett, Richard L. Boortz-Marx, James M. Drake, Stuart DuPen, Steven J. Schneider, Michael S. Turner, Robert J. Coffey

Research output: Contribution to journal › Review article › peer-review

126 Scopus citations

Abstract

Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

Original language	English (US)
Pages (from-to)	1582-1594
Number of pages	13
Journal	Anesthesiology
Volume	100
Issue number	6
DOIs	https://doi.org/10.1097/00000542-200406000-00034
State	Published - Jun 2004
Externally published	Yes

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.1097/00000542-200406000-00034

Fingerprint Dive into the research topics of 'Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections'. Together they form a unique fingerprint.

Cite this

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. / Follett, Kenneth A.; Boortz-Marx, Richard L.; Drake, James M.; DuPen, Stuart; Schneider, Steven J.; Turner, Michael S.; Coffey, Robert J.

In: Anesthesiology, Vol. 100, No. 6, 06.2004, p. 1582-1594.

Research output: Contribution to journal › Review article › peer-review

@article{ab7ee5a1be6c4bbbb297934674f0503e,

title = "Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections",

abstract = "Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.",

author = "Follett, {Kenneth A.} and Boortz-Marx, {Richard L.} and Drake, {James M.} and Stuart DuPen and Schneider, {Steven J.} and Turner, {Michael S.} and Coffey, {Robert J.}",

year = "2004",

month = jun,

doi = "10.1097/00000542-200406000-00034",

language = "English (US)",

volume = "100",

pages = "1582--1594",

journal = "Anesthesiology",

issn = "0003-3022",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

AU - Follett, Kenneth A.

AU - Boortz-Marx, Richard L.

AU - Drake, James M.

AU - DuPen, Stuart

AU - Schneider, Steven J.

AU - Turner, Michael S.

AU - Coffey, Robert J.

PY - 2004/6

Y1 - 2004/6

N2 - Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

AB - Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

UR - http://www.scopus.com/inward/record.url?scp=2542444294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542444294&partnerID=8YFLogxK

U2 - 10.1097/00000542-200406000-00034

DO - 10.1097/00000542-200406000-00034

M3 - Review article

C2 - 15166581

AN - SCOPUS:2542444294

VL - 100

SP - 1582

EP - 1594

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 6

ER -

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this